BioMarin Pharmaceutical has struck a deal to purchase fellow biotechnology firm Amicus Therapeutics for about $4.8 billion in money.
Source link
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion
Related Posts
Waymo, Zoox and Tesla drive 2025 robotaxi boom
Robotaxis felt like science fiction only a decade in the past, however this 12 months, autonomous automobiles turned a commonplace…
Amazon Spring Sale Deal: The Typhur Dome 2 Air Fryer Is 30% Off
I used to be a late convert to air fryers, partially as a result of I apprehensive about versatility: Simply…
Meta commits to spending additional $21 billion with CoreWeave
Arda Kucukkaya | Anadolu | Getty Photographs Meta has dedicated to spending an extra $21 billion on AI cloud infrastructure…